Overview

Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.

Status:
Completed
Trial end date:
2015-12-20
Target enrollment:
Participant gender:
Summary
This study seeks to evaluate the effect of topical aqueous suppression on the anatomic and functional response to intravitreal anti-vascular endothelial growth factor (VEGF) injections in non-responders with wet age-related macular degeneration.
Phase:
Phase 2
Details
Lead Sponsor:
Wills Eye
Collaborators:
J. Arch McNamara Research Fund
Mid Atlantic Retina
Treatments:
Dorzolamide
Endothelial Growth Factors
Timolol